Dongke Yu - Concepedia

Author

Dongke Yu

Chinese Academy of Medical Sciences & Peking Union Medical College

Also Known As

D M Yu, Dong-Ke Yu, Dong-ke Yu, Dongke Yu, Dong‐ke Yu, Lan Zhang, dongke yu

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College University of Electronic Science and Technology of China Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital Yale University Sichuan University

About

Dongke Yu is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in medicine, cell biology, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	370
2	Biochemistry	2	2	25
3	Engineering	1	1	48
4	Health Sciences	1	1	37
5	Natural Sciences	1	1	13

Dongke Yu

Publications

Citations

H-Index

Page 1

	Year	Citations
Probiotics modulate the microbiota–gut–brain axis and improve memory deficits in aged SAMP8 mice Xueqin Yang, Dongke Yu, Xue Li, Acta Pharmaceutica Sinica B	2019	381
CD133<sup>+</sup>EpCAM<sup>+</sup> Phenotype Possesses More Characteristics of Tumor Initiating Cells in Hepatocellular Carcinoma Huh7 Cells Yi Chen, Dongke Yu, Hao Zhang, International Journal of Biological Sciences	2012	96
Chronic periodontitis induces microbiota-gut-brain axis disorders and cognitive impairment in mice Xue Li, Xiao Zou, Xueqin Yang, Experimental Neurology InflammationDental ConditionsDysbiosisAxis DisordersMedicine	2020	74
Hepatic NFAT signaling regulates the expression of inflammatory cytokines in cholestasis Shi‐Ying Cai, Dongke Yu, Carol J. Soroka, Journal of Hepatology ImmunologyPathologyFatty Liver DiseaseCholangiopathiesCellular Physiology	2020	66
The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway Dongke Yu, Cai‐Xia Zhang, Shuangshuang Zhao, Acta Pharmacologica Sinica InflammationPi3k/akt/smad PathwayHepatologyBiliary TractMedicine	2015	65
Costunolide represses hepatic fibrosis through WW domain‐containing protein 2‐mediated Notch3 degradation Mao‐xu Ge, Hong‐tao Liu, Na Zhang, British Journal of Pharmacology	2019	61
Polystyrene microplastics-triggered mitophagy and oxidative burst via activation of PERK pathway Lingai Pan, Dongke Yu, Yuan Zhang, The Science of The Total Environment MicroplasticsPerk PathwayEngineeringBioplasticBiotechnology	2021	48
Cenicriviroc, a cytokine receptor antagonist, potentiates all‐trans retinoic acid in reducing liver injury in cholestatic rodents Dongke Yu, Shi‐Ying Cai, Albert Mennone, Liver International	2018	44
A novel ASBT inhibitor, IMB17-15, repressed nonalcoholic fatty liver disease development in high-fat diet-fed Syrian golden hamsters Mao‐xu Ge, Weixiao Niu, Jinfeng Ren, Acta Pharmacologica Sinica Metabolic SyndromeHepatologyLiver Disease DevelopmentMedicineLiver Physiology	2018	37
Physalin B attenuates liver fibrosis via suppressing LAP2α–HDAC1‐mediated deacetylation of the transcription factor GLI1 and hepatic stellate cell activation Xiaoyun Zhu, Shengtao Ye, Dongke Yu, British Journal of Pharmacology	2021	28

Page 1